Syremis Therapeutics
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $165M
Investors
- 6
About Syremis Therapeutics
Founded in 2025 by co-founders Elisabeth Kogan, Elena Kagan and Menashe Levy and headquartered in Petah Tikva, Israel, Syremis Therapeutics Ltd. specializes in healthcare data analytics solutions. The company is also located in Boston, MA. Syremis specializes in delivering innovative data analytics solutions tailored for the healthcare industry. Their core product offerings focus on advanced health information management systems, which facilitate seamless integration of data across various healthcare platforms. These systems enhance clinical decision-making and operational efficiencies by providing real-time insights into patient care, treatment trends, and resource allocation. The primary end users include hospitals, healthcare providers, and research institutions, which rely on Syremis's solutions to improve patient outcomes and streamline workflows.Syremis generates revenue through a subscription-based model, allowing clients to access their suite of healthcare data analytics tools. Transactions typically involve annual contracts with healthcare institutions, which pay fees corresponding to the scale of services utilized. This structure supports both B2B relationships with large healthcare providers and smaller healthcare facilities seeking to improve their operational capacities. While specific pricing plans for individual products and services are not disclosed, it is understood that Syremis offers tiered solutions, accommodating the varied needs of its clients.In December 2025, Syremis Therapeutics Ltd. The company aims to expand its market presence within North America and Europe, focusing on further enhancing its innovative healthcare solutions.
Who invested in Syremis Therapeutics
6 investors across 1 round
See all investors in Syremis Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 18, 2025
Amount
$165M
Investors
Questions about Syremis Therapeutics
Who invested in Syremis Therapeutics?
Syremis Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Syremis Therapeutics raised?
Syremis Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Syremis Therapeutics last raise money?
Syremis Therapeutics's most recent round on record is a Series A, in Dec 2025.
What does Syremis Therapeutics do?
Founded in 2025 by co-founders Elisabeth Kogan, Elena Kagan and Menashe Levy and headquartered in Petah Tikva, Israel, Syremis Therapeutics Ltd.
Where is Syremis Therapeutics headquartered?
Syremis Therapeutics is headquartered in Petah Tikva, Israel.
Which VCs invest in companies like Syremis Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Syremis Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Syremis Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.